scholarly journals C-C2-05: Primary Care Web-Based Lifestyle Intervention for Type 2 Diabetes: Randomized Controlled Trial to Improve Knowledge and Self-Care

2011 ◽  
Vol 9 (3-4) ◽  
pp. 164-164 ◽  
Author(s):  
M. Rukstalis ◽  
M. A. Blosky ◽  
H. Steinberg ◽  
M. Anglade ◽  
T. Anderer ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Primary Care ◽  
Randomized Controlled Trial ◽  
Lifestyle Intervention ◽  
Controlled Trial ◽  
Self Care ◽  
Web Based ◽  
Randomized Controlled

scholarly journals Web-based self-management with and without coaching for type 2 diabetes patients in primary care: design of a randomized controlled trial

2013 ◽  
Vol 13 (1) ◽  
Author(s):  
Michael van Vugt ◽  
Maartje de Wit ◽  
Steven H Hendriks ◽  
Yvonne Roelofsen ◽  
Henk JG Bilo ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Primary Care ◽  
Randomized Controlled Trial ◽  
Controlled Trial ◽  
Self Management ◽  
Web Based ◽  
Randomized Controlled ◽  
Diabetes Patients

A lifestyle intervention to reduce Type 2 diabetes risk in Dutch primary care: 2.5-year results of a randomized controlled trial

2012 ◽  
Vol 29 (8) ◽  
pp. e223-e231 ◽  
Author(s):  
P. W. A. Vermunt ◽  
I. E. J. Milder ◽  
F. Wielaard ◽  
J. H. M. de Vries ◽  
C. A. Baan ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Primary Care ◽  
Randomized Controlled Trial ◽  
Lifestyle Intervention ◽  
Controlled Trial ◽  
Diabetes Risk ◽  
Randomized Controlled

scholarly journals Structured lifestyle intervention based on a trans-cultural diabetes-specific nutrition algorithm (tDNA) in individuals with type 2 diabetes: a randomized controlled trial

2017 ◽  
Vol 5 (1) ◽  
pp. e000384 ◽  
Author(s):  
Winnie S S Chee ◽  
Harvinder Kaur Gilcharan Singh ◽  
Osama Hamdy ◽  
Jeffrey I Mechanick ◽  
Verna K M Lee ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Randomized Controlled Trial ◽  
Lifestyle Intervention ◽  
Controlled Trial ◽  
Randomized Controlled

The Impact of Web-Based HOT (Healthy Outcomes for Teens) Project on Risk for Type 2 Diabetes: A Randomized Controlled Trial

2014 ◽  
Vol 16 (12) ◽  
pp. 846-852 ◽  
Author(s):  
Henna Muzaffar ◽  
Darla M. Castelli ◽  
Jane Scherer ◽  
Karen Chapman-Novakofski
Keyword(s):  
Type 2 Diabetes ◽  
Randomized Controlled Trial ◽  
Controlled Trial ◽  
Web Based ◽  
Randomized Controlled ◽  
The Impact

scholarly journals Effects of the Proactive Interdisciplinary Self-Management (PRISMA) Program on Online Care Platform Usage in Patients with Type 2 Diabetes in Primary Care: A Randomized Controlled Trial

2020 ◽  
Vol 2020 ◽  
pp. 1-10
Author(s):  
Esther du Pon ◽  
Nanne Kleefstra ◽  
Frits Cleveringa ◽  
Ad van Dooren ◽  
Eibert R. Heerdink ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Primary Care ◽  
Randomized Controlled Trial ◽  
Usual Care ◽  
Controlled Trial ◽  
Self Management ◽  
Online Platform ◽  
Randomized Controlled ◽  
Number Of Patients

Online care platforms can support patients with type 2 diabetes (T2DM) in managing their health. However, in the use of eHealth, a low participation rate is common. The Proactive Interdisciplinary Self-Management (PRISMA) program, aimed at improving patients’ self-management skills, was expected to encourage patients to manage their disease through the use of an online platform. Therefore, the objective of the current study was to investigate whether a group education program can improve the use of an online care platform in patients with T2DM treated by primary care providers in the Netherlands. In a randomized controlled trial, patients with T2DM received either PRISMA with usual care or usual care only. During a six-month follow-up period in 2014-2015, usage (number of log-ons and time spent per session) of an online care platform (e-Vita) aimed at improving T2DM self-management was assessed. A training about the functionalities of e-Vita was offered. The sample consisted of 203 patients. No differences were found between the intervention and control groups in the number of patients who attended the platform training (interested patients) (X21=0.58; p=0.45), and the number of patients who logged on at least once (platform users) (X21=0.46; p=0.50). In addition, no differences were found between the groups in the type of users—patients who logged on twice or more (active users) or patients who logged on once (nonactive users) (X21=0.56; p=0.45). The PRISMA program did not change platform usage in patients with T2DM. In addition, only a small proportion of the patients logged on twice or more. Patients probably need other encouragements to manage their condition using an online platform.

Sign in / Sign up

Export Citation Format

Share Document